AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glycigon-M SR Tablet

Prescription Icon
Prescription Required

Marketer

Aristo Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glycigon-M SR Tablet

Diabetol Duo SR tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This medication helps regulate blood glucose levels. Diabetol Duo SR should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue using this medicine even if you feel well or your blood sugar is controlled; abrupt cessation can lead to elevated blood glucose, potentially causing kidney complications, vision loss, neuropathy, and limb damage. Remember, it’s integral to a comprehensive diabetes management plan including a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a fast-acting sugar source to counteract hypoglycemia and maintain regular mealtimes. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional potential side effects are altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Glycigon-M SR Tablet

Non-insulin-dependent diabetes

Major Benefits of Glycigon-M SR Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glycigon-M SR Tablet with a meal.

Common Side effects of Glycigon-M SR Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glycigon-M SR Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glycigon-M SR Tablets should be administered with food.

How Glycigon-M SR Tablet works:

Glycigon-M SR tablets contain a dual-action formulation of gliclazide and metformin, both medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glycigon-M SR Tablets with alcohol is strongly discouraged due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glycigon-M SR Tablets during pregnancy poses a confirmed risk to the fetus. Therefore, its use is discouraged. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known dangers. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glycigon-M SR Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Glycigon-M SR Tablets cautiously, potentially requiring a modified dosage. Severe kidney disease contraindicates the use of Glycigon-M SR Tablets. Consult your physician. Regular monitoring of kidney function is recommended during treatment with this medication.

LiverLiverCAUTION

Patients with liver impairment should use Glycigon-M SR Tablet cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Glycigon-M SR Tablet is typically initiated at a low dosage; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glycigon-M SR Tablet :

Should you forget a Glycigon-M SR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glycigon-M SR Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Glycigon-M SR Tablet

Glycigon-M SR tablets contain gliclazide and metformin, two medications that manage type 2 diabetes mellitus in adults. This combined therapy enhances blood sugar control when used with a suitable diet and regular physical activity. Gliclazide functions by stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This dual medication is unsuitable for treating type 1 diabetes mellitus.
Glycigon-M SR Tablet administration is linked to several common adverse reactions. These include low blood glucose (hypoglycemia), taste disturbances, nausea, abdominal discomfort, loose stools, cephalalgia, and upper respiratory infections. Serious, though infrequent, adverse events such as lactic acidosis may occur. Prolonged therapy may additionally result in vitamin B12 insufficiency.
Glycigon-M SR Tablet use may result in hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The likelihood increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Glycigon-M SR Tablet use can result in lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this is an uncommon adverse reaction to metformin. To minimize risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and those who consume significant alcohol. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glycigon-M SR Tablet and seek immediate medical attention.
Glycigon-M SR Tablet's prolonged administration can indeed lead to vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Left unaddressed, this deficiency may result in anemia, neurological complications, paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. To mitigate these risks, supplemental vitamin B12 intake, at a minimum of once annually, is recommended by some studies.
Patients with hypersensitivity to any ingredient or inactive component of Glycigon-M SR Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glycigon-M SR Tablet and alcohol is unsafe. This combination can dangerously reduce blood sugar, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glycigon-M SR tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances blood sugar control when coupled with a healthy diet and exercise regimen. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and augments insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glycigon-M SR Tablet may cause common adverse reactions such as low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, loose stools, headache, and upper respiratory infections. Less frequent, but potentially severe, side effects include lactic acidosis. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, Glycigon-M SR Tablets may induce hypoglycemia, characterized by low blood glucose. Manifestations of low blood sugar can encompass nausea, headache, irritability, increased appetite, sweating, vertigo, tachycardia, and feelings of apprehension or tremor. This effect is heightened by skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose sources, such as glucose tablets, honey, or fruit juice, is recommended.
Glycigon-M SR Tablet use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. To mitigate risk, it's contraindicated in individuals with kidney impairment, the elderly, and those who consume significant alcohol. Symptoms potentially indicative of lactic acidosis include muscular pain or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Glycigon-M SR Tablet use and seek immediate medical attention.
Prolonged Glycigon-M SR Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication inhibits the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological complications such as peripheral neuropathy (manifested as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive impairment, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended by some experts, at least annually.
Glycigon-M SR Tablets are contraindicated in individuals hypersensitive to any constituent or inactive ingredient. Their use is also prohibited in patients exhibiting moderate to severe renal impairment or pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Glycigon-M SR Tablet and alcohol is unsafe. Concurrent use may dangerously reduce blood sugar, increasing the risk of lactic acidosis.
Glycigon-M SR Tablet
96
MRP 117
17% off